Select Page
Responsive Centered YouTube Video
Investigation into abnormal clots in embalmers' corpses reveals concerning findings and lack of response from regulatory authorities.
  • Thomas Havland conducted an international survey on abnormal clots in embalmers’ corpses. 1:15

  • Findings showed a high prevalence of white fibrous clots in embalmers’ corpses, with some seeing them as early as 2020. 4:19

  • Results were sent to FDA but no response was received, raising concerns about regulatory oversight. 6:19

Investigation into reluctance of embalmers to conduct autopsies amid pandemic.
  • Reluctance to address issues related to excess deaths and lack of autopsies. 6:38

  • Challenges in obtaining engagement from funeral associations worldwide. 8:10

  • Significant response from embalmers in Pennsylvania to survey on embalming observations. 9:01

  • Observation of psychological barriers hindering questioning and scientific inquiry. 11:00

  • Comparison to scientific observation leading to discoveries like Viagra. 11:18

  • Importance of noticing changes and considering their significance. 11:52

  • Survey sent to funeral homes in various cities in the UK for research. 12:11

Investigation into unusual clotting issues observed by embalmers globally.
  • Survey sent to major funeral director associations, including UK’s National Association of Funeral Directors. 12:20

  • UK’s National Association of Funeral Directors declined to participate in the survey. 12:26

  • Potential reasons for non-participation include employee mandates and personal cognitive dissonance. 12:43

  • Comparison made to historical cases like thalidomide to emphasize the importance of scientific observation. 14:02

  • Importance of correlating observations to understand potential causes of significant health issues. 16:29

  • Survey conducted with unbiased questions to gather information on clotting observations from embalmers. 16:52

  • Second round of data collection completed in January, results sent to FDA, CDC, and NIH. 17:37

Investigation into unusual clots observed by embalmers in recent years.
  • Embalmers were asked about their experience level and number of bodies embalmed per year. 18:15

  • Most embalmers had over 20 years of experience, indicating their expertise. 18:50

  • Average number of bodies embalmed per year was 100, with some embalmers handling over 300. 20:03

  • Embalming process involves injecting embalming fluid to preserve the body and replace blood. 20:18

  • Popular injection sites include carotid artery in the neck and iliac artery in the pelvis. 21:23

  • Some embalmers face challenges with white fibrous clots, leading to longer embalming times. 22:01

  • Majority of embalmers observed large white fibrous clots in corpses embalmed in 2023. 22:13

  • Alarming statistic with 7 out of 10 embalmers reporting the presence of these clots. 22:47

Investigation into unusual blood clots observed by embalmers in 2023 raises concerns about potential health risks.
  • 80% of American adults took the initial two injections, but only 15% took the latest booster in 2023. 23:15

  • Approximately 20% of corpses examined by embalmers in 2023 showed large white fibrous clots. 25:09

  • 79% of embalmers reported observing microclotting in corpses, indicating potential health risks. 28:03

Investigation into unusual blood clot formations in corpses reveals concerning trends.
  • Increased occurrence of coffee ground microclots and grape jelly clots in corpses. 28:16

  • Concern over potential widespread organ dysfunction due to difficult-to-detect clotting. 28:57

  • Challenges in clinical detection of clotting despite significant damage implied. 29:13

  • Embalmer reports indicate a 5x increase in microclot formations since 2019. 29:27

  • Significant rise in prevalence of grape jelly clots from 30% to 40% post-2019. 32:21

  • Observation of varying clot types suggests a complex combination of clotting mechanisms. 33:07

  • Importance of scientific inquiry and research into the observed clotting phenomena. 33:25

  • Embalmer community emphasizes the need for further investigation into the issue. 33:34

Investigation into increased blood clots observed by embalmers across different age groups.
  • Embalmers report significant increase in blood clots, cause unknown. 33:47

  • Scientific community urged to address cause of phenomenon for safety reasons. 34:01

  • Survey results confirm widespread observation of blood clots by embalmers. 34:29

  • 21% of embalmers observed increased infant deaths in 2023 compared to previous years. 35:42

  • 25% increase in infant deaths reported by embalmers who observed the phenomenon. 36:24

  • Blood clots observed across all age groups, with significant increase in 36-50 year olds. 37:36

  • Older age groups show longest bars in increased blood clot observations. 38:09

Concerns raised about unexplained excess mortality and lack of vigilance in the scientific community.
  • High excess mortality rates observed globally over the past three years. 38:43

  • Potential link between cholesterol plaque buildup and age groups 36-50 and 60s. 38:50

  • Call for vigilance and unbiased scientific inquiry to understand and mitigate health issues. 40:09

  • Concerns raised about unexplained excess deaths and the need for urgent action. 41:53

  • Urgent call to address the unexplained excess mortality and hold the scientific community accountable. 42:26

  • Advocacy for transparency and urgency in addressing significant health challenges. 43:45

  • Immediate sharing of research findings with regulatory bodies and authorities for action. 43:51

Investigation of unusual clots found by embalmers reveals concerning data and calls for action from regulatory bodies.
  • White fiberous clots remain an issue in 2023, with over 70% of embalmers still observing them. 45:05

  • Micro clotting has significantly increased, now seen in about 80% of corpses by embalmers. 45:27

  • Grape jelly clots continue to be a problem, with about 40% of corpses showing them in 2023. 45:58

  • An increase in infant deaths and overall clotting of all types has been reported by embalmers. 46:14

  • Data sent to FDA and CDC suggests a need to halt vaccination program for further investigation. 46:41

  • Analysis of clot characteristics reveals unusual composition with low magnesium, potassium, and iron. 48:07

  • High levels of calcium and tin in the clots point towards alternative clotting pathways. 49:34

  • Persistent lack of answers to questions surrounding the clots raises concerns and emphasizes the need for action. 50:00

Uncovering unusual white fibrous clots in bodies post-covid injections, raising concerns among morticians and researchers.
  • Research highlights embalmers encountering extensive clotting in bodies, never seen before, post-covid injections. 50:33

  • Autopsy studies reveal Spike proteins attachment to blood vessel walls, indicating potential risks pre and post-death. 51:04

  • Involves observe rapid formation of white fibrous clots pre-death, leading to strokes and heart attacks. 51:51

  • Debunking past medical books, white fibrous clots emerge as a new phenomenon since 2020, urging further research. 52:55

  • The composition of clots includes fibrin, platelets, and additional proteins, suggesting vessel damage triggers coagulation. 53:47

  • Drawing parallels to military approach, emphasizing the importance of addressing significant findings to prevent adverse outcomes. 55:08

Call for thorough investigation of unusual clotting in embalmers to prevent potential catastrophic outcomes.
  • Urgent need for FDA, CDC, and NIH to analyze data on embalmers’ clotting issues like aircraft safety protocols. 55:43

  • Upcoming discussion on microclotting, emphasizing the importance of further research and autopsies. 56:12

  • Public urged to challenge authorities for answers and ensure thorough investigations to protect public health. 56:36

  • Negligence suggested in not investigating excess deaths and abnormal findings related to embalmers’ clotting issues. 57:16

  • Emphasis on pushing for accountability and protection of public interests in the face of uncertainties. 57:25